Abstract
We have investigated the function and mechanisms of the CARM1-SNF5 complex in T3-dependent transcriptional activation. Using specific small interfering RNAs (siRNA) to knock down coactivators in HeLa α2 cells, we found that coactivator associated arginine methyltransferase 1 (CARM1) and SWI/SNF complex component 5 (SNF5) are important for T3-dependent transcriptional activation. The CARM1- SWI/SNF chromatin remodeling complex serves as a mechanism for the rapid reversal of H3-K9 methylation. Importantly, siRNA treatment against CARM1 and/or SNF5 increased the recruitment of HMTase G9a to the type 1 deiodinase (D1) promoter even with T3. Knocking- down either CARM1 or SNF5 also inhibited the down- regulation of histone macroH2A, which is correlated with transcriptional activation. Finally, knocking down CARM1 and SNF5 by siRNA impaired the association of these coactivators to the D1 promoter, suggesting functional importance of CARM1- SNF5 complex in T3-dependent transcriptional activation.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Choi, HK., Choi, KC., Oh, SY. et al. The functional role of the CARM1-SNF5 complex and its associated HMT activity in transcriptional activation by thyroid hormone receptor. Exp Mol Med 39, 544–555 (2007). https://doi.org/10.1038/emm.2007.60
Published:
Issue Date:
DOI: https://doi.org/10.1038/emm.2007.60
Keywords
This article is cited by
-
Neonatal thyroxine activation modifies epigenetic programming of the liver
Nature Communications (2021)
-
The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties
Signal Transduction and Targeted Therapy (2020)
-
Nuclear receptor coregulators: modulators of pathology and therapeutic targets
Nature Reviews Endocrinology (2012)